Efficacy and Safety of a Multi-Ingredient Liquid-Based Botanical Nutraceutical for Improving Markers of Metabolic Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Many individuals aiming to improve or maintain markers of metabolic and cardiovascular health seek non-pharmacological options with demonstrated efficacy and safety. This study evaluated the efficacy and safety of a multi-ingredient liquid botanical nutraceutical containing organic herbal extracts of turmeric, pomegranate, amla, ginger, and black pepper, as well as niacinamide, CoQ10, folic acid, and lycopene on biomarkers related to cardiovascular health. This was a randomized, double-blind, placebo-controlled clinical trial with a duration of 90 days. The study was conducted at a single center. Participants were healthy adults with normal lipid profiles and were randomized 1:1 to receive the nutraceutical treatment or placebo using simple randomization. Participants received 60 mL of the nutraceutical treatment or placebo twice daily for 90 days, which was orally self-administered. The primary outcome was mean change in low-density lipoprotein (LDL) from baseline to endline. Secondary outcomes were mean changes in high-density lipoprotein, very low-density lipoprotein (VLDL), total cholesterol, triglycerides, adiponectin, apolipoprotein A1, and apolipoprotein B. Outcomes were compared between the treatment and placebo groups using analysis of covariance. Safety was evaluated with liver and kidney function markers and adverse event comparison. Eighty-six participants were randomized (n = 43 per group). From baseline to endline, significant differences between study groups favoring the treatment arm were observed in LDL (treatment vs placebo: −19.21 vs +21.07 mg/dL; p < 0.001). Between-group comparisons also favored the treatment arm for all secondary outcomes (p < 0.05 to p < 0.001). No adverse events were reported. The liquid nutraceutical formula was associated with favorable changes in lipid cardiometabolic markers in healthy adults, suggesting a potential role in supporting lipid homeostasis and attenuating unfavorable lipid trends that typically occur over time.

Authors

Institutions

Publication Details

Journal
Journal of Dietary Supplements
Published
2026-06-26
DOI
https://doi.org/10.1080/19390211.2026.2691821
Primary Topic
Pomegranate: compositions and health benefits
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of a Multi-Ingredient Liquid-Based Botanical Nutraceutical for Improving Markers of Metabolic Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Helen Messier, Ghanashyam Patel, Christopher R. D’Adamo, Niranjankumar Panchal
Journal of Dietary Supplements
Pomegranate: compositions and health benefits
article

Efficacy and Safety of a Multi-Ingredient Liquid-Based Botanical Nutraceutical for Improving Markers of Metabolic Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Helen Messier, Ghanashyam Patel, Christopher R. D’Adamo, Niranjankumar Panchal
article en

Abstract

Many individuals aiming to improve or maintain markers of metabolic and cardiovascular health seek non-pharmacological options with demonstrated efficacy and safety. This study evaluated the efficacy and safety of a multi-ingredient liquid botanical nutraceutical containing organic herbal extracts of turmeric, pomegranate, amla, ginger, and black pepper, as well as niacinamide, CoQ10, folic acid, and lycopene on biomarkers related to cardiovascular health. This was a randomized, double-blind, placebo-controlled clinical trial with a duration of 90 days. The study was conducted at a single center. Participants were healthy adults with normal lipid profiles and were randomized 1:1 to receive the nutraceutical treatment or placebo using simple randomization. Participants received 60 mL of the nutraceutical treatment or placebo twice daily for 90 days, which was orally self-administered. The primary outcome was mean change in low-density lipoprotein (LDL) from baseline to endline. Secondary outcomes were mean changes in high-density lipoprotein, very low-density lipoprotein (VLDL), total cholesterol, triglycerides, adiponectin, apolipoprotein A1, and apolipoprotein B. Outcomes were compared between the treatment and placebo groups using analysis of covariance. Safety was evaluated with liver and kidney function markers and adverse event comparison. Eighty-six participants were randomized (n = 43 per group). From baseline to endline, significant differences between study groups favoring the treatment arm were observed in LDL (treatment vs placebo: −19.21 vs +21.07 mg/dL; p < 0.001). Between-group comparisons also favored the treatment arm for all secondary outcomes (p < 0.05 to p < 0.001). No adverse events were reported. The liquid nutraceutical formula was associated with favorable changes in lipid cardiometabolic markers in healthy adults, suggesting a potential role in supporting lipid homeostasis and attenuating unfavorable lipid trends that typically occur over time.

Journal of Dietary Supplements
University of Mary (US), Altarum Institute (US), XLAB (Slovenia) (SI), Green Solution (Czechia) (CZ), Ovation Fertility (US), Unity Hospital (US)
Good health and well-being
Openalex Percentile: Top 8%
Pomegranate: compositions and health benefits
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.